The Future of Medicine

Developing New Categories of Medicine

Our goal is to improve and extend the lives of patients through the development of breakthrough medicine

Exploring the Brain Immune Gut (BIG) Axis

PureTech Health is pioneering the development of therapeutics based on the crosstalk and biology of the Brain-Immune-Gut Axis

Giving Life to Science

Our goal is to improve and extend the lives of patients

The biopharma company of the future

Discovery Reinvented

Publications -2018-03-23
PureTech's Lymphatic Leap
Publications -2017-09-19
Gamma Delta T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation

CD4(+) T regulatory cells (T(regs)), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T(regs) were most abundant in the colonic mucosa.

Full Article

Publications -2017-09-19
Science: The Gut’s Clostridium Cocktail
PureTech’s CEO Daphne Zohar speaks on panel titled “Innovate Like a Start-Up: A New Future for R&D?” at the Financial Times Global Pharmaceutical and Biotechnology Conference in London
Press releases
Bristol-Myers Squibb and PureTech’s Vedanta Biosciences Announce New Immuno-Oncology Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers


Press releases
PureTech’s Vor Granted Foundational US Patent Broadly Covering Compositions and Methods to Treat Haematologic Malignancies